E Cannabis And Psychedelic Drug Stock Performances Were Mixed Last Week

Image by Игорь Левченко from Pixabay

The munKNEE Pure-Play Marijuana-Based & Psychedelic Compounds-Based Drug Stocks Index consists of 8 constituents in each of the munKNEE Pure-Play Marijuana-Based Drug Stocks Index and the munKNEE Pure-Play Psychedelic Compounds-Based Drug Stocks Index. Which out-performed last week? This article has the answer. Here are the details:

One hundred clinical-stage psychedelic drug stocks now trade on North American stock exchanges. Sixty of the stocks research the treatment of a variety of mental illnesses based on the use of 10 different psychedelic substances (read 10 Psychedelic Substances And The 35 Companies Researching Them) and 40 research the treatment of illnesses based on the use of THC marijuana (read Marijuana Drug Stocks: All You Need To Know).

The criteria for inclusion in the munKNEE Pure-Play Marijuana-Based & Psychedelic Compounds-Based Drug Stocks Index is that its constituents have market capitalizations in excess of $50M but less than $500M and only 16 of the 100 psychedelic drug stocks meet that criteria. The remaining 84 stocks in the Index have market caps below $50M or are above $500M. The latter include ATAI, Compass Pathways, Mind Medicine, and GH Resources and they are not included in the index given their very large market caps and high share prices which would have dominated the index's performance. (All currency amounts are in U.S. dollars. Go here to convert to another currency.)

The Pure-Play Marijuana-Based Drug Stocks Category

The 8 marijuana-based clinical-stage stocks

  • were DOWN -14.2% last week and
  • are now UP +12.2% YTD,
  • ranged in price from $0.03/share to $4.47/share (an average of $1.44/share) as of Friday,
  • and have an average market capitalization of approximately $104M.

Those that changed in price by +/- 5% last week are presented below in descending order including YTD percentage movements:

1 2 3
View single page >> |

Visit  munKNEE.com and register to receive our free Market Intelligence Report newsletter (sample  more

How did you like this article? Let us know so we can better customize your reading experience.


Leave a comment to automatically be entered into our contest to win a free Echo Show.